AstraZeneca (AZN) Receives a Hold from Jefferies


Jefferies analyst Ian Hilliker maintained a Hold rating on AstraZeneca (AZN) today and set a price target of $42. The company’s shares opened today at $39.14.

Hilliker has an average return of 11.0% when recommending AstraZeneca.

According to TipRanks.com, Hilliker is ranked #1250 out of 5108 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for AstraZeneca with a $51 average price target.

See today’s analyst top recommended stocks >>

Based on AstraZeneca’s latest earnings release for the quarter ending September 30, the company reported a quarterly net profit of $432 million. In comparison, last year the company had a net profit of $690 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts